(C) Reuters. FILE PHOTO: Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – Pfizer Inc (NYSE:PFE) and Moderna (NASDAQ:MRNA) Inc has raised the prices of its COVID-19 vaccine in the latest European Union supply contracts, The Financial Times reported https://on.ft.com/3j8mbTb on Sunday.
The new price for the Pfizer shot was 19.50 euros ($23.15)against 15.50 euros previously, the newspaper said citing to the portions of the contracts seen.
The price of a Moderna vaccine was $25.50 a dose, the contracts show, up from 19 euros in the first procurement deal but lower than the previously agreed $28.50 because the order had grown, the report said, citing one official close to the matter.
($1 = 0.8425 euros)
Pfizer and Moderna raise prices for its COVID-19 vaccines in EU- FT
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.